Search

Author/Creator Hamon, Pauline

1. Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages. Issue 1 (21st June 2020)

Authors:
Meziani, Lydia; Gerbé de Thoré, Marine; Hamon, Pauline; Bockel, Sophie; Louzada, Ruy A; Clemenson, Céline; Corre, Raphaël; Liu, Winchygn; Dupuy, Corinne; Mondini, Michele; Deutsch, Eric
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. (March 2022)

Authors:
Marron, Thomas U; Fiel, Maria Isabel; Hamon, Pauline; Fiaschi, Nathalie; Kim, Edward; Ward, Stephen C; Zhao, Zhen; Kim, Joel; Kennedy, Paul; Gunasekaran, Ganesh; Tabrizian, Parissa; Doroshow, Deborah; Legg, Meredith; Hammad, Ashley; Magen, Assaf; Kamphorst, Alice O; Shareef, Muhammed; Gupta, Nami...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 3(2022)
Page Start:
219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy. Issue 3 (17th March 2022)

Authors:
Hamon, Pauline; Gerbé De Thoré, Marine; Classe, Marion; Signolle, Nicolas; Liu, Winchygn; Bawa, Olivia; Meziani, Lydia; Clémenson, Céline; Milliat, Fabien; Deutsch, Eric; Mondini, Michele
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗